Novynette Continuu (Desogestrel, Ethinylestradiol | Lactose Anhydrous)

Desogestrel, the active ingredient in Novynette Continuu, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age.

GNH USA supplies Novynette Continuu as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Novynette Continuu is a combined oral contraceptive that works within the hormonal regulation pathway to prevent ovulation. - Contraception: Provides reliable prevention of pregnancy when taken as directed. - Menstrual cycle regulation: Helps achieve more predictable menstrual bleeding patterns. - Acne improvement: Reduces androgen‑driven skin lesions in some women taking the contraceptive.

Novynette Continuu may cause a range of adverse reactions.

Common Side Effects: - Nausea - Headache - Breast tenderness - Weight gain - Mood changes - Spotting between periods

Serious or Rare Side Effects: - Deep vein thrombosis - Pulmonary embolism - Stroke - Myocardial infarction - Severe allergic reaction (anaphylaxis)

Before using Novynette Continuu, consider several safety measures. - Smoking status: Women who smoke and > 60 years age should avoid the product. - Cardiovascular risk: Assess the individual risk for thrombo‑   - Cardi t ?  t t  t  t t t

-   t  t ewline -   -  ewline -  ewline - Store at below 25°C: keep in the original pack and protect from moist  t ewline

The   t  t 

t  ewline  ewline

ewline

".